HEPATITIS-B SURFACE-ANTIGEN REACTIVITY IN MAN DUE TO A NEW VARIANT OF HEPATITIS-B VIRUS

被引:8
作者
COURSAGET, P
YVONNET, B
BOURDIL, C
BUISSON, Y
CHOTARD, J
NDOYE, R
MOLINIE, C
DIOPMAR, I
CHIRON, JP
机构
[1] HOP INSTRUCT ARMEES BEGIN,F-94160 ST MANDE,FRANCE
[2] HOP VAL DE GRACE,PARIS,FRANCE
[3] FAC PHARM TOURS,INST VIROL,F-37042 TOURS,FRANCE
[4] FAC MED & PHARM DAKAR,DAKAR,SENEGAMBIA
关键词
anti-HBc; core antigen; epitopes; HBeAg; HBsAg; hepatitis B vaccination; Hepatitis B virus;
D O I
10.1016/0264-410X(90)90208-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A new type of hepatitis B virus (HBV) infection has been encountered in Senegalese infants and French adults characterized by serum hepatitis B surface antigen (HBsAg) without antibodies to the core antigen (anti-HBc). As the infection is not associated with the presence of the e antigen, it differs from HBV in its core antigen. After teh loss of HBsAg, neither anti-HBs not antibodies to HBsAg (anti-HBs) become detectable. This new infection (called HBV2 as opposed to the classical HBV1 infection) was found in infants with anti-HBs, either naturally acquired or produced by immunization against HBV. The use of monoclonal anti-HBs antibodies showed that two epitopes of HBV1 surface antigen could be detected in HBV2-positive sera. HBV DNA sequences could only be found in one of 15 HBV2-infected children using a DNA-DNA hybridization proceduer; low levels of HBV DNA were also detected in 58% of the HBsAg-positive adult sera tested. if this new infection, apparently related to HBV1, is shown to cause chronic liver disease, hepatitis B vaccine should also contain surface antigen from HBV2. © 1990.
引用
收藏
页码:S15 / S17
页数:3
相关论文
共 14 条
[1]  
BUDKOWSKA A, 1988, LANCET, V1, P656
[2]   BLOOD-DONORS POSITIVE FOR HBSAG AND NEGATIVE FOR ANTI-HBC ANTIBODY [J].
COUROUCE, AM ;
DROUET, J ;
LEMARREC, N ;
DROUET, A ;
SOULIER, JP .
VOX SANGUINIS, 1985, 49 (01) :26-33
[3]  
COURSAGET P, 1986, LANCET, V2, P1143
[4]  
COURSAGET P, 1987, LANCET, V2, P1354
[5]   ANTI-PRE-S2 ANTIBODIES IN NATURAL HEPATITIS-B VIRUS-INFECTION AND AFTER IMMUNIZATION [J].
COURSAGET, P ;
ADAMOWICZ, P ;
BOURDIL, C ;
YVONNET, B ;
BUISSON, Y ;
BARRES, JL ;
SALIOU, P ;
CHIRON, JP ;
MAR, ID .
VACCINE, 1988, 6 (04) :357-361
[6]  
ECHEVARRIA JM, 1988, LANCET, V2, P1315
[7]  
HOLLAND PV, 1985, HEPATITIS B, P5
[8]  
MAUPAS P, 1981, LANCET, V1, P289
[9]  
OVERBY LR, 1981, VIRAL HEPATITIS, P169
[10]  
ROBINSON WS, 1985, HEPATITIS B, P319